glimepiride vs pramlintide
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of glimepiride and pramlintide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
The following are examples of medications that may increase the glucose-lowering effect of sulfonylureas including glimepiride, increasing the susceptibility to and/or intensity of hypoglycemia: oral anti-diabetic medications, pramlintide acetate, insulin, angiotensin converting enzyme (ACE) inhibitors, H 2 receptor antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly...
Amaryl
Symlin
Glimepiride is a medicine that helps lower blood sugar in adults with type 2 diabetes. It works along with diet and exercise.
Symlin is a drug that helps control blood sugar in people with type 1 or type 2 diabetes who also use insulin. It works with insulin to lower blood sugar levels after meals.
Glimepiride is used to help control blood sugar levels in adults with type 2 diabetes. It should be used with a healthy diet and regular exercise. This medicine will not work for type 1 diabetes or diabetic ketoacidosis.
Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes. You should already be using insulin at mealtimes. This medicine is for people whose blood sugar is not well-controlled, even with the best insulin treatment.
Glimepiride helps your body release more insulin. Insulin helps move sugar from your blood into your cells for energy. This lowers your blood sugar levels.
Symlin is similar to a natural hormone in your body. It slows down how quickly food leaves your stomach. It also helps to prevent your liver from releasing too much sugar after you eat, and reduces your appetite.
- • Low blood sugar
- • Headache
- • Nausea
- • Dizziness
- • Nausea
- • Vomiting
- • Loss of appetite
- • Headache
- • Fatigue
- Blood Glucose Increased 2,970
- Nausea 2,276
- Diarrhoea 2,169
- Fatigue 1,827
- Hypoglycaemia 1,639
- High blood sugar 15
- Sudden kidney damage 11
- Long-term kidney disease 11
- Feeling sick to your stomach 9
- Shortness of breath 8
Glimepiride can cause low blood sugar, which can be severe. Be careful when driving or operating machinery. If you have an allergic reaction, stop taking glimepiride right away. People with a certain enzyme problem (G6PD deficiency) may get anemia.
Symlin can cause very low blood sugar, especially if you have type 1 diabetes. This can happen within 3 hours after a Symlin shot. To avoid this, follow your doctor's instructions carefully and check your blood sugar often. Make sure you know the signs of low blood sugar.
Tell your doctor if you are pregnant or plan to become pregnant. Glimepiride may not be safe for your baby. It is usually stopped 2 weeks before delivery.
It is not known if Symlin will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Symlin passes into breast milk, so discuss breastfeeding with your doctor.
Also Compare, Nearby Drugs
Compare glimepiride with
How to Read This glimepiride vs pramlintide Comparison
glimepiride is classified in the Sulfonylurea drug class, while pramlintide sits within the Amylin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, glimepiride has 10,881 submissions while pramlintide has 54. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to both of these medicines lower blood sugar, so using them at the same time can make your blood sugar drop to unsafe levels.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for glimepiride or pramlintide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.